 | • レポートコード：B-GIR08C4850 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ラムシルマブの世界市場について調べ、まとめました。種類別セグメントは、100ミリグラム /箱、500ミリグラム /箱等、用途別セグメントは、フラットパネルディスプレイ、光ディスク、自動車・建築用ガラス、Webコーティング、装飾、ハードコーティング、太陽電池、光通信、磁気データ記憶装置、半導体等に区分しました。ラムシルマブの世界市場概観、企業動向、企業別ラムシルマブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ラムシルマブの市場概観 ・ラムシルマブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ラムシルマブの企業別販売動向、市場シェア、市場集中度、競争動向 ・ラムシルマブの世界市場規模 ・ラムシルマブの北米市場分析（アメリカ、カナダ、メキシコ等） ・ラムシルマブのアメリカ市場規模推移 ・ラムシルマブのカナダ市場規模推移 ・ラムシルマブのメキシコ市場規模推移 ・ラムシルマブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ラムシルマブのドイツ市場規模推移 ・ラムシルマブのイギリス市場規模推移 ・ラムシルマブのロシア市場規模推移 ・ラムシルマブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ラムシルマブの日本市場規模推移 ・ラムシルマブの中国市場規模推移 ・ラムシルマブの韓国市場規模推移 ・ラムシルマブのインド市場規模推移 ・ラムシルマブの東南アジア市場規模推移 ・ラムシルマブの南米市場分析（ブラジル、アルゼンチン等） ・ラムシルマブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ラムシルマブの種類別分析/販売量、売上、市場シェア（100ミリグラム /箱、500ミリグラム /箱） ・ラムシルマブの用途別分析/市場規模（フラットパネルディスプレイ、光ディスク、自動車・建築用ガラス、Webコーティング、装飾、ハードコーティング、太陽電池、光通信、磁気データ記憶装置、半導体） ・ラムシルマブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ラムシルマブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Ramucirumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Ramucirumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Eli Lilly
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
100mg/Box
500mg/Box
Market Segment by Applications, can be divided into
Advanced Gastric Cancer
GEJ Adenocarcinoma
Non-small Cell Lung Carcinoma
Metastatic Colorectal Cancer (mCRC)
Hepatocellular Carcinoma (HCC)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ramucirumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ramucirumab, with price, sales, revenue and global market share of Ramucirumab in 2017 and 2018.
Chapter 3, the Ramucirumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ramucirumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Ramucirumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Ramucirumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Ramucirumab Introduction
1.2 Market Analysis by Type
1.2.1 100mg/Box
1.2.2 500mg/Box
1.3 Market Analysis by Applications
1.3.1 Advanced Gastric Cancer
1.3.2 GEJ Adenocarcinoma
1.3.3 Non-small Cell Lung Carcinoma
1.3.4 Metastatic Colorectal Cancer (mCRC)
1.3.5 Hepatocellular Carcinoma (HCC)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Ramucirumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Ramucirumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Ramucirumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Ramucirumab Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Ramucirumab Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Ramucirumab Manufacturer Market Share in 2018
3.3.2 Top 6 Ramucirumab Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Ramucirumab Market Analysis by Regions
4.1 Global Ramucirumab Sales, Revenue and Market Share by Regions
4.1.1 Global Ramucirumab Sales and Market Share by Regions (2014-2019)
4.1.2 Global Ramucirumab Revenue and Market Share by Regions (2014-2019)
4.2 North America Ramucirumab Sales and Growth Rate (2014-2019)
4.3 Europe Ramucirumab Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Ramucirumab Sales and Growth Rate (2014-2019)
4.5 South America Ramucirumab Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Ramucirumab Sales and Growth Rate (2014-2019)
5 North America Ramucirumab by Country
5.1 North America Ramucirumab Sales, Revenue and Market Share by Country
5.1.1 North America Ramucirumab Sales and Market Share by Country (2014-2019)
5.1.2 North America Ramucirumab Revenue and Market Share by Country (2014-2019)
5.2 United States Ramucirumab Sales and Growth Rate (2014-2019)
5.3 Canada Ramucirumab Sales and Growth Rate (2014-2019)
5.4 Mexico Ramucirumab Sales and Growth Rate (2014-2019)
6 Europe Ramucirumab by Country
6.1 Europe Ramucirumab Sales, Revenue and Market Share by Country
6.1.1 Europe Ramucirumab Sales and Market Share by Country (2014-2019)
6.1.2 Europe Ramucirumab Revenue and Market Share by Country (2014-2019)
6.2 Germany Ramucirumab Sales and Growth Rate (2014-2019)
6.3 UK Ramucirumab Sales and Growth Rate (2014-2019)
6.4 France Ramucirumab Sales and Growth Rate (2014-2019)
6.5 Russia Ramucirumab Sales and Growth Rate (2014-2019)
6.6 Italy Ramucirumab Sales and Growth Rate (2014-2019)
7 Asia-Pacific Ramucirumab by Country
7.1 Asia-Pacific Ramucirumab Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Ramucirumab Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Ramucirumab Revenue and Market Share by Country (2014-2019)
7.2 China Ramucirumab Sales and Growth Rate (2014-2019)
7.3 Japan Ramucirumab Sales and Growth Rate (2014-2019)
7.4 Korea Ramucirumab Sales and Growth Rate (2014-2019)
7.5 India Ramucirumab Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Ramucirumab Sales and Growth Rate (2014-2019)
8 South America Ramucirumab by Country
8.1 South America Ramucirumab Sales, Revenue and Market Share by Country
8.1.1 South America Ramucirumab Sales and Market Share by Country (2014-2019)
8.1.2 South America Ramucirumab Revenue and Market Share by Country (2014-2019)
8.2 Brazil Ramucirumab Sales and Growth Rate (2014-2019)
8.3 Argentina Ramucirumab Sales and Growth Rate (2014-2019)
8.4 Colombia Ramucirumab Sales and Growth Rate (2014-2019)
9 Middle East and Africa Ramucirumab by Countries
9.1 Middle East and Africa Ramucirumab Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Ramucirumab Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Ramucirumab Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Ramucirumab Sales and Growth Rate (2014-2019)
9.3 Turkey Ramucirumab Sales and Growth Rate (2014-2019)
9.4 Egypt Ramucirumab Sales and Growth Rate (2014-2019)
9.5 Nigeria Ramucirumab Sales and Growth Rate (2014-2019)
9.6 South Africa Ramucirumab Sales and Growth Rate (2014-2019)
10 Global Ramucirumab Market Segment by Type
10.1 Global Ramucirumab Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Ramucirumab Sales and Market Share by Type (2014-2019)
10.1.2 Global Ramucirumab Revenue and Market Share by Type (2014-2019)
10.2 100mg/Box Sales Growth and Price
10.2.1 Global 100mg/Box Sales Growth (2014-2019)
10.2.2 Global 100mg/Box Price (2014-2019)
10.3 500mg/Box Sales Growth and Price
10.3.1 Global 500mg/Box Sales Growth (2014-2019)
10.3.2 Global 500mg/Box Price (2014-2019)
11 Global Ramucirumab Market Segment by Application
11.1 Global Ramucirumab Sales Market Share by Application (2014-2019)
11.2 Advanced Gastric Cancer Sales Growth (2014-2019)
11.3 GEJ Adenocarcinoma Sales Growth (2014-2019)
11.4 Non-small Cell Lung Carcinoma Sales Growth (2014-2019)
11.5 Metastatic Colorectal Cancer (mCRC) Sales Growth (2014-2019)
11.6 Hepatocellular Carcinoma (HCC) Sales Growth (2014-2019)
12 Ramucirumab Market Forecast (2019-2024)
12.1 Global Ramucirumab Sales, Revenue and Growth Rate (2019-2024)
12.2 Ramucirumab Market Forecast by Regions (2019-2024)
12.2.1 North America Ramucirumab Market Forecast (2019-2024)
12.2.2 Europe Ramucirumab Market Forecast (2019-2024)
12.2.3 Asia-Pacific Ramucirumab Market Forecast (2019-2024)
12.2.4 South America Ramucirumab Market Forecast (2019-2024)
12.2.5 Middle East and Africa Ramucirumab Market Forecast (2019-2024)
12.3 Ramucirumab Market Forecast by Type (2019-2024)
12.3.1 Global Ramucirumab Sales Forecast by Type (2019-2024)
12.3.2 Global Ramucirumab Market Share Forecast by Type (2019-2024)
12.4 Ramucirumab Market Forecast by Application (2019-2024)
12.4.1 Global Ramucirumab Sales Forecast by Application (2019-2024)
12.4.2 Global Ramucirumab Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Ramucirumab Picture
Table Product Specifications of Ramucirumab
Figure Global Sales Market Share of Ramucirumab by Types in 2018
Table Ramucirumab Types for Major Manufacturers
Figure 100mg/Box Picture
Figure 500mg/Box Picture
Figure Ramucirumab Sales Market Share by Applications in 2018
Figure Advanced Gastric Cancer Picture
Figure GEJ Adenocarcinoma Picture
Figure Non-small Cell Lung Carcinoma Picture
Figure Metastatic Colorectal Cancer (mCRC) Picture
Figure Hepatocellular Carcinoma (HCC) Picture
Figure United States Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure France Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure UK Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure China Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure India Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Ramucirumab Revenue (Value) and Growth Rate (2014-2024)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Ramucirumab Type and Applications
Table Eli Lilly Ramucirumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Ramucirumab Sales by Manufacturer (2017-2018)
Figure Global Ramucirumab Sales Market Share by Manufacturer in 2017
Figure Global Ramucirumab Sales Market Share by Manufacturer in 2018
Table Global Ramucirumab Revenue by Manufacturer (2017-2018)
Figure Global Ramucirumab Revenue Market Share by Manufacturer in 2017
Figure Global Ramucirumab Revenue Market Share by Manufacturer in 2018
Figure Top 3 Ramucirumab Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Ramucirumab Manufacturer (Revenue) Market Share in 2018
Figure Global Ramucirumab Sales and Growth Rate (2014-2019)
Figure Global Ramucirumab Revenue and Growth Rate (2014-2019)
Table Global Ramucirumab Sales by Regions (2014-2019)
Table Global Ramucirumab Sales Market Share by Regions (2014-2019)
Table Global Ramucirumab Revenue by Regions (2014-2019)
Figure Global Ramucirumab Revenue Market Share by Regions (2014-2019)
Figure Global Ramucirumab Revenue Market Share by Regions in 2018
Figure North America Ramucirumab Sales and Growth Rate (2014-2019)
Figure Europe Ramucirumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Ramucirumab Sales and Growth Rate (2014-2019)
Figure South America Ramucirumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Ramucirumab Sales and Growth Rate (2014-2019)
Figure North America Ramucirumab Revenue and Growth Rate (2014-2019)
Table North America Ramucirumab Sales by Countries (2014-2019)
Table North America Ramucirumab Sales Market Share by Countries (2014-2019)
Figure North America Ramucirumab Sales Market Share by Countries (2014-2019)
Figure North America Ramucirumab Sales Market Share by Countries in 2018
Table North America Ramucirumab Revenue by Countries (2014-2019)
Table North America Ramucirumab Revenue Market Share by Countries (2014-2019)
Figure North America Ramucirumab Revenue Market Share by Countries (2014-2019)
Figure North America Ramucirumab Revenue Market Share by Countries in 2018
Figure United States Ramucirumab Sales and Growth Rate (2014-2019)
Figure Canada Ramucirumab Sales and Growth Rate (2014-2019)
Figure Mexico Ramucirumab Sales and Growth Rate (2014-2019)
Figure Europe Ramucirumab Revenue and Growth Rate (2014-2019)
Table Europe Ramucirumab Sales by Countries (2014-2019)
Table Europe Ramucirumab Sales Market Share by Countries (2014-2019)
Table Europe Ramucirumab Revenue by Countries (2014-2019)
Figure Europe Ramucirumab Revenue Market Share by Countries (2014-2019)
Figure Europe Ramucirumab Revenue Market Share by Countries in 2018
Figure Germany Ramucirumab Sales and Growth Rate (2014-2019)
Figure UK Ramucirumab Sales and Growth Rate (2014-2019)
Figure France Ramucirumab Sales and Growth Rate (2014-2019)
Figure Russia Ramucirumab Sales and Growth Rate (2014-2019)
Figure Italy Ramucirumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Ramucirumab Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Ramucirumab Sales by Countries (2014-2019)
Table Asia-Pacific Ramucirumab Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Ramucirumab Sales Market Share by Countries 2018
Table Asia-Pacific Ramucirumab Revenue by Countries (2014-2019)
Figure Asia-Pacific Ramucirumab Revenue Market Share by Countries 2018
Figure China Ramucirumab Sales and Growth Rate (2014-2019)
Figure Japan Ramucirumab Sales and Growth Rate (2014-2019)
Figure Korea Ramucirumab Sales and Growth Rate (2014-2019)
Figure India Ramucirumab Sales and Growth Rate (2014-2019)
Figure Southeast Asia Ramucirumab Sales and Growth Rate (2014-2019)
Figure South America Ramucirumab Revenue and Growth Rate (2014-2019)
Table South America Ramucirumab Sales by Countries (2014-2019)
Table South America Ramucirumab Sales Market Share by Countries (2014-2019)
Figure South America Ramucirumab Sales Market Share by Countries in 2018
Table South America Ramucirumab Revenue by Countries (2014-2019)
Table South America Ramucirumab Revenue Market Share by Countries (2014-2019)
Figure South America Ramucirumab Revenue Market Share by Countries in 2018
Figure Brazil Ramucirumab Sales and Growth Rate (2014-2019)
Figure Argentina Ramucirumab Sales and Growth Rate (2014-2019)
Figure Colombia Ramucirumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Ramucirumab Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Ramucirumab Sales by Countries (2014-2019)
Table Middle East and Africa Ramucirumab Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Ramucirumab Sales Market Share by Countries in 2018
Table Middle East and Africa Ramucirumab Revenue by Countries (2014-2019)
Table Middle East and Africa Ramucirumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Ramucirumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Ramucirumab Revenue Market Share by Countries in 2018
Figure Saudi Arabia Ramucirumab Sales and Growth Rate (2014-2019)
Figure UAE Ramucirumab Sales and Growth Rate (2014-2019)
Figure Egypt Ramucirumab Sales and Growth Rate (2014-2019)
Figure Nigeria Ramucirumab Sales and Growth Rate (2014-2019)
Figure South Africa Ramucirumab Sales and Growth Rate (2014-2019)
Table Global Ramucirumab Sales by Type (2014-2019)
Table Global Ramucirumab Sales Share by Type (2014-2019)
Table Global Ramucirumab Revenue by Type (2014-2019)
Table Global Ramucirumab Revenue Share by Type (2014-2019)
Figure Global 100mg/Box Sales Growth (2014-2019)
Figure Global 100mg/Box Price (2014-2019)
Figure Global 500mg/Box Sales Growth (2014-2019)
Figure Global 500mg/Box Price (2014-2019)
Table Global Ramucirumab Sales by Application (2014-2019)
Table Global Ramucirumab Sales Share by Application (2014-2019)
Figure Global GEJ Adenocarcinoma Sales Growth (2014-2019)
Figure Global Non-small Cell Lung Carcinoma Sales Growth (2014-2019)
Figure Global Metastatic Colorectal Cancer (mCRC) Sales Growth (2014-2019)
Figure Global Hepatocellular Carcinoma (HCC) Sales Growth (2014-2019)
Figure Global Ramucirumab Sales, Revenue and Growth Rate (2019-2024)
Table Global Ramucirumab Sales Forecast by Regions (2019-2024)
Table Global Ramucirumab Market Share Forecast by Regions (2019-2024)
Figure North America Sales Ramucirumab Market Forecast (2019-2024)
Figure Europe Sales Ramucirumab Market Forecast (2019-2024)
Figure Asia-Pacific Sales Ramucirumab Market Forecast (2019-2024)
Figure South America Sales Ramucirumab Market Forecast (2019-2024)
Figure Middle East and Africa Sales Ramucirumab Market Forecast (2019-2024)
Table Global Ramucirumab Sales Forecast by Type (2019-2024)
Table Global Ramucirumab Market Share Forecast by Type (2019-2024)
Table Global Ramucirumab Sales Forecast by Application (2019-2024)
Table Global Ramucirumab Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
非小細胞肺がん市場：世界及び中国の市場分析・予測（～2024年） Non-small Cell Lung Cancer Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Non-small Cell Lung Cancer industry with a focus on the Chinese market. The report provides key statistics on the market status of the Non-small Cell L…- 非小細胞肺癌治療薬市場：世界及び中国市場分析・予測（～2024年） Drugs for Non-small Cell Lung Cancer Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Drugs for Non-small Cell Lung Cancer industry with a focus on the Chinese market. The report provides key statistics on the market status of …
- 世界の転移性大腸がんの治療市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- 世界の転移性結腸直腸がん手術市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- 子宮頸がん治療の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Cervical Cancer Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Cervical Canc…